CN105832946A - Medicine for treating human cancer and production method thereof - Google Patents
Medicine for treating human cancer and production method thereof Download PDFInfo
- Publication number
- CN105832946A CN105832946A CN201610277937.2A CN201610277937A CN105832946A CN 105832946 A CN105832946 A CN 105832946A CN 201610277937 A CN201610277937 A CN 201610277937A CN 105832946 A CN105832946 A CN 105832946A
- Authority
- CN
- China
- Prior art keywords
- medicine
- cancer
- production method
- allicin
- treating human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/24—Mucus; Mucous glands; Bursa; Synovial fluid; Arthral fluid; Excreta; Spinal fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a medicine for treating human cancer and a production method thereof, and belongs to the technical field of medicines .The medicine is prepared from flocuxacin, trogopterus dung, ipomoea cairica roots, rhizoma cyperi, costus roots, hairyvein agrimonia herbs and buds, walnut green seedcase, allicin and ganoderma lucidum .The medicine has the effects of eliminating evil, strengthening the body resistance, dredging collaterals, removing toxicity for detumescence, removing stasis for promoting the circulation of qi, promoting blood circulation to remove blood stasis, softening hard mass and removing stasis, pain of a cancer patient can be relieved, and the life of the cancer patient can be prolonged.
Description
Technical field
The invention belongs to pharmaceutical technology field, a kind of medicine that can treat cancer and production method thereof.
Background technology
Cancer is the fatal killer of human health, and the most worldwide the treatment Main for cancer is:
1, operation.Its good effect is to alleviate pressure symptom, removes visible knurl body, releases patient painful.Deficiency
Place is to perform the operation all to there is certain wound, causes immunity degradation.Operation also cannot remove all cancer cells, it is impossible to control transfer and
Recurrence.
2, chemotherapy.Its positive role is, comprehensively uses with operation and immunotherapy, can be effectively improved some clinic and control
Therapeutic effect.Weak point is in addition to minority specific tumor, the most efficient only 30-40%, and chemotherapeutic selective is strong, due to by disease
Species sensitivity is limited, the strongest, and high curative effect disease kind is few, and tolerance occurs fast, short application use effect still can, apply for a long time
Effect is decreased obviously, and after transfer and relapse, reapplies effect worse, and side effect is relatively big, outstanding to the local normal tissue injury of body
For seriously.
3, radiotherapy.Its good effect is under certain condition, can reduce knurl body to greatest extent, kills cancer group born of the same parents.No
It is that side effect is relatively big in place of foot, efficient the highest, and easily recur.
4, biological immune therapy.Positive role is to improve immunity of organisms constantly, can be effective against tumour, cuts off
Tumor vessel, stops its fast-growth, shifts and recurs.Weak point is low dose of DeGrain, heavy dose of toxic and side effect
Greatly.
5, blood vessel blocking therapy, positive role is to block blood vessel, tumour hungry to death.Weak point is that effect is slow, the cycle
Long.
6, gene therapy.Its positive role is by gene repair or amendment, changes the biological property of cancer cell, reaches
To the purpose eliminating cancer cell.Weak point is to be only applicable to minority particular patient.
7, tcm therapy.Chinese traditional treatment cancer is often based on righting reinforcing, clearing heat and detoxicating, combats poison with poison as conventional compatibility
Method.Its positive role is to debate disease on the whole to treat.Weak point is, slow curative effect, the most preferably combines medicine
Thing.
In a word, also there is no a kind of Perfected process that can treat cancer and ideal medicament in world wide.
Summary of the invention
It is an object of the invention to develop a kind of composition of medicine that can effectively suppress and cure cancer so that the disease of cancer
People the most extremely or to greatest extent extends its life cycle.For reaching above-mentioned purpose, we are through test of many times, filter out following joining
Side:
Detailed description of the invention
Below in conjunction with embodiment, the present invention is further elaborated.
Fill a prescription as follows:
Add up to 96g.It is above 1 staggering amount, divides and take for 3-4 time, within 7 days, be 1 course for the treatment of.Take medicine is to take with lemonade.Lemon
The preparation method of water is, lemon is steeped in water, and ratio is lemon: water=1: 3；Then boiled for this lemonade standby.
This medicament can make the tablet described in pharmacy, granule by the technology known, it is possible to dresses up capsule.
In said medicine is filled a prescription:
The husky star of fluorine is the intermediate product that the antibiotic microorganism such as Norfloxacin, Ofloxacin produces, former powder be white or
Off-white powder, is the derivative of a kind of antibiotic, former antibiotic detoxification synergy form.Its mechanism of action is by suppression cancer
The activity of cell DNA helicase stops synthesis and the duplication of cancer cell DNA, thus suppresses or cause the death of cancer cell.
Allicin is naturally occurring in the bulb of liliaceous plant garlic, forms through certain processes.Use allicin
The immune indexes for the treatment of patient shows, after accepting treatment, and the phagocytic rate of most of patients macrophage and lymphocyte transformation rate
All significantly improving, CAMP is the negative signal of growth of tumour cell, and any approach improves the intracellular the most interchangeable suppression of CAMP level
The growth of tumour cell, promotes it to break up.Allicin can improve CAMP level in tumor tissues, can suppress the excessive of tumor tissues
Growing multiplication, can inducing apoptosis of tumour cell.
After green peel of walnut i.e. walnut maturation, the rascal that outer layer is wrapped up in, after drying, it is this medicine.
Other Chinese medicine is common drug, and shop of Chinese medicines is on sale.
In order to verify the positive effect of the present invention, inventor has carried out great many of experiments, now selects partial clinical test report
As follows:
Case 1: Zhang, man, 65 years old, through Nanyang, hospital was diagnosed as cancer of the stomach.After taking three courses for the treatment of of this medicine, through check
Transference cure, clinical recovery.
Case 2: poplar, female, 59 years old, it is diagnosed as intestinal cancer through county, hospital of city.After taking this medicament one month, again check disease
Shape disappears.Clinical recovery.
Case 3: high so-and-so, man, 68 years old, be diagnosed as liver cancer through county, hospital of city.Once in Nanyang, Zhengzhou make chemotherapy, radiotherapy,
Causing serious sequelae, cancer continues to deteriorate.Reexamine after taking this medicament one and a half months, transference cure, clinical recovery.
Case 4: Lee so-and-so, female, 45 years old, be diagnosed as breast cancer through county, hospital of city.After taking this medicine 2 months, feel
Well, through check transference cure, clinical recovery.
Case 5: beam so-and-so, man, 57 years old, be diagnosed as lung cancer through county, hospital of city.Recur again after chemotherapy, radiotherapy.Take this medicine
Check in latter 3 months, transference cure, clinical recovery.
It was verified that this composition of medicine energy eliminating pathogen to support vital qi, get through channels and collaterals, removing toxicity for detumescence, dissipating bind promoting the circulation of qi, promoting blood circulation and removing blood stasis, soft
Heavily fortified pointization is tied, and releases cancer patient painful, delays cancer patient's life.
Claims (2)
1. the medicine treating cancer, it is characterised in that: this medicine by fluorine quinoline sand star, excrementum pteropi, black lead a cow, the rhizome of nutgrass flatsedge, extensively wood
Perfume, hairyvein agrimony, snake are de-, green peel of walnut, allicin, glossy ganoderma composition.
2., according to the medicine of the treatment cancer described in claims 1, its formula is calculated as fluorine quinoline sand star 0.5-with a daily dose
1.5g, excrementum pteropi 6-12g, the black 10-15g of leading a cow, rhizome of nutgrass flatsedge 6-12g, costus root 6-12g, hairyvein agrimony 15-25g, snake take off 2-4g,
Green peel of walnut 10-20g, allicin 0.5-1.5g, glossy ganoderma 6-12g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610277937.2A CN105832946A (en) | 2016-04-23 | 2016-04-23 | Medicine for treating human cancer and production method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610277937.2A CN105832946A (en) | 2016-04-23 | 2016-04-23 | Medicine for treating human cancer and production method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105832946A true CN105832946A (en) | 2016-08-10 |
Family
ID=56590033
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610277937.2A Withdrawn CN105832946A (en) | 2016-04-23 | 2016-04-23 | Medicine for treating human cancer and production method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105832946A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108524909A (en) * | 2018-05-30 | 2018-09-14 | 崔明华 | A kind of drug and its production method for curing human cancer |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101530573A (en) * | 2009-04-08 | 2009-09-16 | 张进党 | Chinese medicine for treating tumor |
| CN103417877A (en) * | 2012-05-23 | 2013-12-04 | 余长成 | Cancer treatment and prevention by utilization of herbal medicine |
| CN104623597A (en) * | 2015-01-15 | 2015-05-20 | 姜文 | Medicinal composition for treating pain and fever of cancer patient and preparation method thereof |
-
2016
- 2016-04-23 CN CN201610277937.2A patent/CN105832946A/en not_active Withdrawn
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101530573A (en) * | 2009-04-08 | 2009-09-16 | 张进党 | Chinese medicine for treating tumor |
| CN103417877A (en) * | 2012-05-23 | 2013-12-04 | 余长成 | Cancer treatment and prevention by utilization of herbal medicine |
| CN104623597A (en) * | 2015-01-15 | 2015-05-20 | 姜文 | Medicinal composition for treating pain and fever of cancer patient and preparation method thereof |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108524909A (en) * | 2018-05-30 | 2018-09-14 | 崔明华 | A kind of drug and its production method for curing human cancer |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103861079B (en) | Traditional Chinese medicine composition with effects of clearing heat, relieving pain and eliminating tumors | |
| CN104491740B (en) | A kind of Chinese medicine composition for treating liver cancer and preparation method thereof | |
| CN101711848B (en) | Chinese medicinal composition capable of adjunctively treating tumour | |
| CN104491220B (en) | A kind of traditional Chinese medicine composition for herpes | |
| CN101810337A (en) | Health food containing pseudo-ginseng and ganoderma lucidum and radix astragali | |
| CN103705846B (en) | The Chinese medicine preparation for the treatment of ovarian cyst | |
| CN105832946A (en) | Medicine for treating human cancer and production method thereof | |
| CN1284599C (en) | Medicine for treating tumor and its preparation process | |
| CN104758451A (en) | Traditional Chinese medicine composite for treating gout | |
| CN105617062A (en) | Traditional Chinese medicine composition used for treating lung cancer, and preparation method and applications thereof | |
| CN104825817B (en) | A kind of Chinese medicine preparation with antitumor action | |
| CN108057107A (en) | A kind of pharmaceutical composition of rapid drop and elimination malignant tumour and preparation method thereof | |
| CN102805799A (en) | Traditional Chinese medicine composition with antitumous effect | |
| CN103784689A (en) | Medicinal composition for treating leukemia | |
| CN105902748A (en) | Medicine for curing human cancer and production method thereof | |
| CN1270755C (en) | Pharmaceutical composition for treating rheumatic arthritis and rheumatoid arthritis | |
| CN104027447A (en) | Traditional Chinese medicine for treating cancer | |
| CN104027719A (en) | Traditional Chinese medicine compound composition capable of treating hypersplenism liver-depression and spleen-deficiency type diseases caused by infectious endocarditis and preparation method thereof | |
| CN103550681A (en) | Traditional Chinese medicine (TCM) composition for treating hepatitis B | |
| CN103768328A (en) | Medicinal magnetic plaster for treating tumors | |
| CN108992498A (en) | A kind of natural traditional Chinese medicine liver-protecting tea and preparation method thereof | |
| CN103127295B (en) | One is treated leukemic Chinese medicine | |
| CN104857422B (en) | It treats the composition of colorectal cancer and is used to prepare the purposes for the treatment of large intestine cancer drug | |
| CN100350950C (en) | Wuzishan Chinese medicines for cancer pains | |
| CN102824461A (en) | Medicine for treating hypertension and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160810 |
|
| WW01 | Invention patent application withdrawn after publication |